drugset / Trial / NCT05946785

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

NCT05946785

Phase 0 Recruiting 28 enrolled Anna Stanhewicz, PhD
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this investigation is to examine the role of oxidative stress in aberrant microvascular function in otherwise healthy women with a history of GDM.

Timeline

Start
2023-07-01
Primary completion
2026-12-31
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcholine Small molecule Other
Subject insulin aspart Protein / enzyme biologic Other

Indications